Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1365
https://www.valueinhealthjournal.com/article/S1098-3015(16)32731-0/fulltext
Title :
Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32731-0&doi=10.1016/j.jval.2016.09.1365
First page :
A583
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1283